Loading…

Janus phenomenon : The interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis

Saved in:

Bibliographic Details
Published in:	Circulation (New York, N.Y.) N.Y.), 2004-06, Vol.109 (23), p.2826-2831
Main Authors:	EPSTEIN, Stephen E, STABILE, Eugenio, KINNAIRD, Timothy, CHEOL WHAN LEE, CLAVIJO, Leonardo, BURNETT, Mary Susan
Format:	Article
Language:	English
Subjects:	Angiogenesis Inducing Agents - adverse effects Angiogenesis Inducing Agents - pharmacology Angiogenesis Inducing Agents - therapeutic use Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - pharmacology Angiogenesis Inhibitors - therapeutic use Animals Arteriosclerosis - chemically induced Arteriosclerosis - genetics Arteriosclerosis - prevention & control Biological and medical sciences Blood and lymphatic vessels Blood. Blood coagulation. Reticuloendothelial system Cardiology. Vascular system Cardiovascular system Chemokines - physiology Collateral Circulation - drug effects Cytokines - physiology Disease Progression Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Genetic Predisposition to Disease Humans Inflammation Medical sciences Metabolic Syndrome - metabolism Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Nude Miscellaneous Models, Biological Nitric Oxide - physiology Pharmacology. Drug treatments T-Lymphocyte Subsets - immunology Time Factors
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!